NASDAQ:CYTK
Cytokinetics Stock News
$64.02
-1.25 (-1.92%)
At Close: May 09, 2024
Cytokinetics to Hold Annual Meeting of Stockholders
04:00pm, Wednesday, 05'th May 2021
SOUTH SAN FRANCISCO, Calif., May 05, 2021 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that its Annual Meeting of Stockholders will be held on Wednesday, May 12, 2021
Astellas Walks Away From $450M Research & Discovery Partnership With Cytokinetics
02:48pm, Monday, 03'rd May 2021
Cytokinetics Inc (NASDAQ: CYTK) revealed in an SEC filing that Astellas Pharma Inc (OTCMKTS: ALPMY) is walking away from a pact to research and develop skeletal sarcomere activators for diseases
Cytokinetics Announces Preclinical Data for CK-3773274 Presented at the American Chemical Society Spring 2021 Virtual Meeting
07:30am, Monday, 12'th Apr 2021
Next-In-Class Cardiac Myosin Inhibitor Optimized for Shallow Exposure Response and Pharmacokinetics to Enable Flexible Dose Titration Next-In-Class Cardiac Myosin Inhibitor Optimized for Shallow Expos
Cytokinetics to Participate in the 20th Annual Needham Virtual Healthcare Conference
04:00pm, Monday, 05'th Apr 2021
SOUTH SAN FRANCISCO, Calif., April 05, 2021 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that Robert I. Blum, President and Chief Executive Officer, is scheduled to pa
SOUTH SAN FRANCISCO, Calif., April 02, 2021 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that data relating to CK-3773274 (CK-274), including data regarding its discov
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:00pm, Thursday, 01'st Apr 2021
SOUTH SAN FRANCISCO, Calif., April 01, 2021 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on March 31, 2021 it granted stock options to purchase an aggregate of 16
Cytokinetics (CYTK) is Overbought: Is A Drop Coming?
07:57am, Thursday, 18'th Mar 2021
Cytokinetics (CYTK) has moved higher as of late, but there could definitely be trouble on the horizon for this company
Cytokinetics to Participate in Upcoming Investor Conferences
04:00pm, Tuesday, 02'nd Mar 2021
SOUTH SAN FRANCISCO, Calif., March 02, 2021 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that Robert I. Blum, President and Chief Executive Officer, is scheduled to pr
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:32pm, Friday, 26'th Feb 2021
SOUTH SAN FRANCISCO, Calif., Feb. 26, 2021 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on February 26, 2021 it granted stock options to purchase an aggregate of
Cytokinetics Joins Global Initiative to Recognize International Rare Disease Day
07:30am, Friday, 26'th Feb 2021
SOUTH SAN FRANCISCO, Calif., Feb. 26, 2021 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on February 28 it is joining the European Organisation for Rare Diseases
Cytokinetics, Inc. (CYTK) CEO Robert Blum on Q4 2020 Results - Earnings Call Transcript
02:19am, Friday, 26'th Feb 2021
Cytokinetics, Inc. (CYTK) CEO Robert Blum on Q4 2020 Results - Earnings Call Transcript
Cytokinetics Names Muna Bhanji to Board of Directors
07:30am, Thursday, 18'th Feb 2021
Appointment Adds to Board Expertise in Commercial Development and Market Access as Company Prepares for Further Corporate Development Appointment Adds to Board Expertise in Commercial Development and
Cytokinetics to Announce Fourth Quarter Results on February 25, 2021
04:00pm, Thursday, 11'th Feb 2021
SOUTH SAN FRANCISCO, Calif., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that it is scheduled to report fourth quarter results on February 25, 2021 at 4
Cytokinetics Announces Recipients of Third Annual Communications Fellowship Grants
07:30am, Tuesday, 02'nd Feb 2021
Total of $100,000 Awarded to Five Organizations to Support Communications and Community Outreach Total of $100,000 Awarded to Five Organizations to Support Communications and Community Outreach
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:00pm, Monday, 01'st Feb 2021
SOUTH SAN FRANCISCO, Calif., Feb. 01, 2021 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on January 29, 2021 it granted stock options to purchase an aggregate of 1